secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVANOS MEDICAL, INC. (AVNS)
CIK:        0001606498
Form:       8-K
Filed at:   2025-03-17T23:59:59+00:00
Accession:  0001606498-25-000057
Event type: leadership
Sentiment:  positive
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avanos Medical names David Pacitti as CEO, effective April 14, 2025
-------------------------------------------------------------------

- David Pacitti appointed CEO of Avanos Medical, effective April 14, 2025.
- Pacitti was President & Head of the Americas at Siemens Healthineers.
- Base salary $1.05M, bonus target 110%, 2026 LTI target $5M.
- One-time $500K cash sign-on and $7M in equity awards ($3.5M PRSUs + $3.5M TRSUs).
- Pacitti will succeed interim CEO Michael Greiner.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1606498/000160649825000057/0001606498-25-000057-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1606498/000160649825000057/avns-20250314.htm
  HTML page:      https://secwatch.observer/filing/0001606498-25-000057

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer